Lactose Intolerance Treatment Market Report 2026
Global Outlook – By Treatment (Food Supplements, Enzyme Lactase Supplements, Probiotics, Other Treatments), By Intolerance Type (Primary Lactose Intolerance, Secondary Lactose Intolerance, Congenital Lactose Intolerance, Developmental Lactose Intolerance), By Route Of Administration (Oral, Injectable), By End Users (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Lactose Intolerance Treatment Market Overview
• Lactose Intolerance Treatment market size has reached to $34.43 billion in 2025 • Expected to grow to $49.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Rise In Global Population Propels The Lactose Intolerance Treatment Market • Market Trend: Technological Advancement Transforms The Market • North America was the largest region in 2025.What Is Covered Under Lactose Intolerance Treatment Market?
Lactose intolerance treatment is a treatment for a condition that causes symptoms in the digestive system. It is a digestive disorder in which enough lactase is not produced. This condition can cause abdominal pain, flatulence, bloating, cramps, acidity, and diarrhea. A natural enzyme (lactase) produced by the body is substituted in the treatment of lactose intolerance. The treatments involved in lactose intolerance treatment are food supplements, enzyme lactase supplements, probiotics and others. Food supplements are defined as those that are designed to make up for nutritional deficiencies, ensure an adequate intake of specific nutrients, or support particular physiological functions. The intolerance types involved are primary lactose intolerance, secondary lactose intolerance, congenital lactose intolerance, and developmental lactose intolerance that are administered through oral and injectable methods. They are used by hospitals, homecare, specialty clinics, and other end users.
What Is The Lactose Intolerance Treatment Market Size and Share 2026?
The lactose intolerance treatment market size has grown strongly in recent years. It will grow from $34.43 billion in 2025 to $36.96 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to rising lactose intolerance prevalence, limited availability of lactose-free products, low consumer awareness, reliance on traditional remedies, increasing gastrointestinal disorders.What Is The Lactose Intolerance Treatment Market Growth Forecast?
The lactose intolerance treatment market size is expected to see strong growth in the next few years. It will grow to $49.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing demand for personalized therapies, technological advancements in enzyme formulations, expansion of functional dairy alternatives, increased healthcare expenditure, rising homecare adoption. Major trends in the forecast period include personalized lactose intolerance therapies, growth of functional foods and dairy alternatives, increased adoption of enzyme supplements, awareness and education on digestive health, expansion of home-based treatment solutions.
Global Lactose Intolerance Treatment Market Segmentation
1) By Treatment: Food Supplements, Enzyme Lactase Supplements, Probiotics, Other Treatments 2) By Intolerance Type: Primary Lactose Intolerance, Secondary Lactose Intolerance, Congenital Lactose Intolerance, Developmental Lactose Intolerance 3) By Route Of Administration: Oral, Injectable 4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Food Supplements: Lactose-Free Dairy Products, Fortified Foods 2) By Enzyme Lactase Supplements: Capsules, Tablets, Chewable Tablets, Liquid Formulations 3) By Probiotics: Probiotic Yogurts, Probiotic Capsules, Probiotic Powders 4) By Other Treatments: Dietary Modifications, Prescription MedicationsWhat Is The Driver Of The Lactose Intolerance Treatment Market?
The lactose intolerance treatment market is expected to be supported by the rising global population in the forecast period. The rise in global population expansion and changing dietary patterns has led to the rise in number of individuals with lactose intolerance, leading to growing demand for effective treatments and management solutions. This demographic shift, coupled with a heightened awareness of lactose intolerance, is likely to drive innovation and investment in therapeutic options. For instance, in January 2024, according to the United States Census Bureau, a U.S.-based government agency, the global population is projected to reach 8,019,876,189, an increase of 75,162,541 (0.95%) from 2023. Thus, the increasing population will drive the demand for lactose intolerance treatment industry.Key Players In The Global Lactose Intolerance Treatment Market
Major companies operating in the lactose intolerance treatment market are Abbott Laboratories Inc., Macleods Pharmaceuticals Limited, Ganeden Inc., Deerland Probiotics & Enzymes Inc., Novozymes A/S, Cargill Incorporated, Lupin Pharmaceuticals Inc., Nestlé S.A., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Wockhardt Ltd., Alkem Laboratories Limited, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., DuPont Nutrition & Biosciences Inc., Kerry Group plc, Koninklijke DSM N.V., Solvay S.A., Chr. Hansen Holding A/S, Bio-Cat Inc.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Lactose Intolerance Treatment Market Trends and Insights
Major companies operating in the lactose intolerance treatment market are focusing on developing innovative solutions, such as advanced sugar-reduction and lactose-modification technologies, to meet the rising demand for low-lactose, low-sugar, and digestion-friendly dairy products. These technologies work by enzymatically breaking down lactose and reducing natural sugar content, offering a functional alternative to traditional lactose-free processing methods while enhancing nutritional profiles. For instance, in July 2023, Nestlé, a Switzerland-based food and drink processing company, introduced a versatile, cost-effective sugar-reduction technology that can be applied across multiple product categories. This technology not only reduces total sugars but can also be used to create low-lactose and skimmed milk-based products, addressing both lactose intolerance and sugar-reduction needs in consumersWhat Are Latest Mergers And Acquisitions In The Lactose Intolerance Treatment Market?
In December 2023, Kerry Group plc, an Ireland-based taste & nutrition company, acquired part of the global lactase enzyme business of Chr. Hansen Holding A/S and Novozymes A/S for an undisclosed amount. This acquisition aligns with Kerry’s strategic focus on expanding its biotechnology solutions and enabling the production of lactose-free and sugar-reduced dairy products, addressing the growing consumer demand driven by lactose intolerance. Novozymes A/S, a Denmark-based biotechnology company, specializes in developing industrial enzymes and microbial solutions for applications across agriculture, food, bioenergy, and household care.
Regional Insights
North America was the largest region in the lactose intolerance treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Lactose Intolerance Treatment Market?
The lactose intolerance treatment market consists of sales of lactase enzyme products, tablets and drops that contain lactase. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Lactose Intolerance Treatment Market Report 2026?
The lactose intolerance treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lactose intolerance treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Lactose Intolerance Treatment Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $36.96 billion |
| Revenue Forecast In 2030 | $49.13 billion |
| Growth Rate | CAGR of 7.3% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Treatment, Intolerance Type, Route Of Administration, End Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Abbott Laboratories Inc., Macleods Pharmaceuticals Limited, Ganeden Inc., Deerland Probiotics & Enzymes Inc., Novozymes A/S, Cargill Incorporated, Lupin Pharmaceuticals Inc., Nestlé S.A., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Wockhardt Ltd., Alkem Laboratories Limited, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., DuPont Nutrition & Biosciences Inc., Kerry Group plc, Koninklijke DSM N.V., Solvay S.A., Chr. Hansen Holding A/S, Bio-Cat Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |